Precigen, Inc. (PGEN)
6.385
-0.81
(-11.26%)
USD |
NASDAQ |
Oct 16, 16:00
6.38
0.00 (0.00%)
After-Hours: 20:00
Precigen Net Income (TTM) : -157.70M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -157.70M |
| March 31, 2026 | -204.42M |
| December 31, 2025 | -250.64M |
| September 30, 2025 | -246.87M |
| June 30, 2025 | -124.50M |
| March 31, 2025 | -156.65M |
| December 31, 2024 | -126.24M |
| September 30, 2024 | -139.56M |
| June 30, 2024 | -135.38M |
| March 31, 2024 | -96.91M |
| December 31, 2023 | -95.90M |
| September 30, 2023 | -85.02M |
| June 30, 2023 | -72.87M |
| March 31, 2023 | -78.61M |
| December 31, 2022 | -79.78M |
| September 30, 2022 | -84.30M |
| June 30, 2022 | -102.97M |
| March 31, 2022 | -107.85M |
| December 31, 2021 | -105.80M |
| September 30, 2021 | -80.07M |
| June 30, 2021 | -81.29M |
| March 31, 2021 | -66.06M |
| December 31, 2020 | -65.06M |
| September 30, 2020 | -100.17M |
| June 30, 2020 | -121.68M |
| Date | Value |
|---|---|
| March 31, 2020 | -138.28M |
| December 31, 2019 | -170.33M |
| September 30, 2019 | -408.85M |
| June 30, 2019 | -418.54M |
| March 31, 2019 | -453.06M |
| December 31, 2018 | -443.39M |
| September 30, 2018 | -202.75M |
| June 30, 2018 | -184.84M |
| March 31, 2018 | -137.68M |
| December 31, 2017 | -126.82M |
| September 30, 2017 | -137.79M |
| June 30, 2017 | -126.96M |
| March 31, 2017 | -157.33M |
| December 31, 2016 | -190.27M |
| September 30, 2016 | -178.64M |
| June 30, 2016 | -187.66M |
| March 31, 2016 | -179.12M |
| December 31, 2015 | -87.99M |
| September 30, 2015 | -36.79M |
| June 30, 2015 | -51.62M |
| March 31, 2015 | -63.06M |
| December 31, 2014 | -85.62M |
| September 30, 2014 | -116.57M |
| June 30, 2014 | -47.71M |
| March 31, 2014 | -1.297M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Anika Therapeutics, Inc. | -3.121M |
| Aldeyra Therapeutics, Inc. | -23.05M |
| Repligen Corp. | 41.54M |
| AC Immune SA | -54.32M |
| Amgen, Inc. | 8.743B |